US 10675360
Targeted therapeutics
granted A61KA61K31/4196A61K31/454
Quick answer
US patent 10675360 (Targeted therapeutics) held by Madrigal Pharmaceuticals, Inc. expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Madrigal Pharmaceuticals, Inc.
- Grant date
- Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/4196, A61K31/454, A61K31/4745, A61K31/496